CCM
Catalio Capital Management Portfolio holdings
AUM
$477M
This Quarter Return
+9.82%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$457M
AUM Growth
–
Cap. Flow
+$457M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
57.34%
Holding
33
New
33
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Becton Dickinson
BDX
|
$33.7M |
| 2 |
Ascendis Pharma
ASND
|
$29.7M |
| 3 |
Bristol-Myers Squibb
BMY
|
$28.2M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$27.6M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$24.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kyverna Therapeutics
KYTX
$161M
| $2.2M | 0.48% |
+586,909
| New | +$2.2M |
|
27
Metagenomi
MGX
$67.2M
| $1.91M | 0.42% |
+528,993
| New | +$1.91M |
|
28
Karyopharm Therapeutics
KPTI
$61.4M
| $1.58M | 0.35% |
+2,334,375
| New | +$1.58M |
|
|
ZBIO
29
Zenas BioPharma, Inc. Common Stock
ZBIO
$722M
| $1.53M | 0.34% |
+187,184
| New | +$1.53M |
|
30
Hyperfine
HYPR
$88M
| $669K | 0.15% |
+760,035
| New | +$669K |
|
31
Fractyl Health
GUTS
$66.2M
| $441K | 0.1% |
+214,236
| New | +$441K |
|
32
ATAI Life Sciences
ATAI
$969M
| $262K | 0.06% |
+196,858
| New | +$262K |
|
33
Sensei Biotherapeutics
SNSE
$10.9M
| $144K | 0.03% |
+294,374
| New | +$144K |
|